ClinicalTrials.gov
ClinicalTrials.gov Menu

Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01137968
Recruitment Status : Completed
First Posted : June 7, 2010
Last Update Posted : January 26, 2016
Sponsor:
Information provided by (Responsible Party):
Geron Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2013
  Actual Study Completion Date : September 2013
  Certification/Extension First Submitted : March 13, 2015